pTSA: Posterior Approach to Total Shoulder Arthroplasty

Sponsor
The Orthopaedic Research & Innovation Foundation (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03623269
Collaborator
(none)
31
1
87
0.4

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate preoperative objective measurements and operative objective measurements to determine if there is any effect to postoperative outcomes. Patients who were 18 years old or greater at the time of surgery were followed clinically and radiographically to determine best practice and optimal treatment and technique, risk and rate of complication, and postoperative outcomes.

Condition or Disease Intervention/Treatment Phase
  • Procedure: posterior approach to total shoulder arthroplasty

Study Design

Study Type:
Observational
Actual Enrollment :
31 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Posterior Approach to Total Shoulder Arthroplasty: A Data Analysis on Patients Undergoing the Posterior Approach to Total Shoulder Arthroplasty
Actual Study Start Date :
Oct 1, 2017
Anticipated Primary Completion Date :
Aug 31, 2023
Anticipated Study Completion Date :
Dec 31, 2024

Outcome Measures

Primary Outcome Measures

  1. recovery [preoperative to 6 months postoperatively]

    American shoulder and elbow score (ASES) with a range from 0-100, with 0 being worst outcome and 100 being best outcome

  2. recovery [preoperative to 6 months postoperatively]

    Simple Shoulder Test score (SST) with a range from 0-12 with 12 being the best score and 0 being the worst score.

  3. recovery [preoperative to 6 months postoperatively]

    range of motion

  4. complications [6 months postoperative]

    percent of complications

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. English speaking

  2. 18 years of age

  3. Underwent posterior approach to total shoulder arthroplasty by Dr. Michael Greiwe at St. Elizabeth Healthcare

Exclusion Criteria:
  1. Non-English speaking

  2. <18 years of age

  3. Loose bone in the anterior recess of the shoulder

  4. Severe arthritis with significant bony deformity

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Orthopaedic Research & Innovation Foundation Edgewood Kentucky United States 41017

Sponsors and Collaborators

  • The Orthopaedic Research & Innovation Foundation

Investigators

  • Principal Investigator: R M Greiwe, MD, The Orthopaedic Research & Innovation Foundation

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
The Orthopaedic Research & Innovation Foundation
ClinicalTrials.gov Identifier:
NCT03623269
Other Study ID Numbers:
  • ORIF.005
First Posted:
Aug 9, 2018
Last Update Posted:
May 30, 2019
Last Verified:
May 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 30, 2019